Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aesgen
Princeton, New Jersey, USAaesgen.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Aesgen was a specialty pharmaceutical company based in Princeton, New Jersey, that focused on the development of generic injectable products for the US market. The company specialized in creating complex formulations and navigating the regulatory requirements for Abbreviated New Drug Applications (ANDAs). In November 2015, Aesgen was acquired by Hikma Pharmaceuticals through its US subsidiary, West-Ward Pharmaceuticals. The acquisition included Aesgen's pipeline of seven products, notably including Caffeine Citrate, which strengthened Hikma's position in the specialty injectables space. Aesgen's expertise in non-aqueous and other complex delivery systems was a key driver for the transaction.
- Therapeutic areas
- Pulmonology
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Aesgen.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aesgen.